These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 32159729

  • 21. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
    Teulings HE, Overkamp M, Ceylan E, Nieuweboer-Krobotova L, Bos JD, Nijsten T, Wolkerstorfer AW, Luiten RM, van der Veen JP.
    Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
    [Abstract] [Full Text] [Related]

  • 22. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
    Phan K, Ramachandran V, Fassihi H, Sebaratnam DF.
    JAMA Dermatol; 2019 Mar 01; 155(3):335-341. PubMed ID: 30698622
    [Abstract] [Full Text] [Related]

  • 23. Serum levels of homocysteine, folate and vitamin B12 in patients with vitiligo before and after treatment with narrow band ultraviolet B phototherapy and in a group of controls.
    Ataş H, Cemil BÇ, Gönül M, Baştürk E, Çiçek E.
    J Photochem Photobiol B; 2015 Jul 01; 148():174-180. PubMed ID: 25941975
    [Abstract] [Full Text] [Related]

  • 24. Surrounding Needling and Narrowband Ultraviolet B Phototherapy Treatment: Synergistic Effects for Repigmentation in Chronic, Stable Nonsegmental Vitiligo.
    Chu GY, Weng SM, Huang CC, Liang WC, Hsu CH.
    Altern Ther Health Med; 2023 Jan 01; 29(1):96-103. PubMed ID: 35212646
    [Abstract] [Full Text] [Related]

  • 25. Risk of Melanoma and Nonmelanoma Skin Cancer in People with Vitiligo: United Kingdom Population-Based Cohort Study.
    Ferguson J, Eleftheriadou V, Nesnas J.
    J Invest Dermatol; 2023 Nov 01; 143(11):2204-2210. PubMed ID: 37146674
    [Abstract] [Full Text] [Related]

  • 26. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
    Bae JM, Chung KY, Yun SJ, Kim H, Park BC, Kim JS, Seo SH, Ahn HH, Lee DY, Kim YC, Park HJ, Kim M.
    J Clin Oncol; 2019 Apr 10; 37(11):903-911. PubMed ID: 30785828
    [Abstract] [Full Text] [Related]

  • 27. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A, Kanwar AJ, Parsad D, De D.
    J Eur Acad Dermatol Venereol; 2007 Nov 10; 21(10):1381-5. PubMed ID: 17958845
    [Abstract] [Full Text] [Related]

  • 28. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
    Almohideb M, Walsh S, Walsh S, Shear N, Alhusayen R.
    Clin Lymphoma Myeloma Leuk; 2017 Sep 10; 17(9):604-612. PubMed ID: 28711574
    [Abstract] [Full Text] [Related]

  • 29. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients.
    Yang YS, Cho HR, Ryou JH, Lee MH.
    Int J Dermatol; 2010 Mar 10; 49(3):317-23. PubMed ID: 20465673
    [Abstract] [Full Text] [Related]

  • 30. The effects of UVB irradiance on vitiligo phototherapy and UVB-induced photocarcinogenesis.
    Yang TT, Chiu SH, Lan CE.
    Photodermatol Photoimmunol Photomed; 2020 Jul 10; 36(4):257-262. PubMed ID: 32022939
    [Abstract] [Full Text] [Related]

  • 31. Acceleration of melanocyte senescence by the proinflammatory cytokines IFNγ and TNFα impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy.
    Dong BQ, Liao ZK, Le Y, Jiang S, Luo LF, Miao F, Le Poole IC, Lei TC.
    Mech Ageing Dev; 2023 Apr 10; 211():111779. PubMed ID: 36731753
    [Abstract] [Full Text] [Related]

  • 32. The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review.
    Sokolova A, Lee A, D Smith S.
    Am J Clin Dermatol; 2015 Dec 10; 16(6):501-31. PubMed ID: 26369540
    [Abstract] [Full Text] [Related]

  • 33. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
    Paradisi A, Tabolli S, Didona B, Sobrino L, Russo N, Abeni D.
    J Am Acad Dermatol; 2014 Dec 10; 71(6):1110-6. PubMed ID: 25242557
    [Abstract] [Full Text] [Related]

  • 34. Treatment of oral graft-versus-host disease with intraoral nbUVB phototherapy.
    Choi E, Lenga M, Nguyen CV, Zheng L, Froelich A, Centanni E, Choi JN.
    Support Care Cancer; 2024 Jun 17; 32(7):438. PubMed ID: 38880860
    [Abstract] [Full Text] [Related]

  • 35. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients.
    Percivalle S, Piccino R, Caccialanza M, Forti S.
    G Ital Dermatol Venereol; 2008 Feb 17; 143(1):9-14. PubMed ID: 18833047
    [Abstract] [Full Text] [Related]

  • 36. Photocarcinogenic Risk Associated With Narrowband UV-B Phototherapy: An Epidemiologic Study in a Tertiary Care Hospital.
    Ortiz-Salvador JM, Ferrer DS, Saneleuterio-Temporal M, Victoria Martínez AM, Ferriols AP, Vilata Corell JJ, Alegre de Miquel V.
    Actas Dermosifiliogr (Engl Ed); 2018 May 17; 109(4):340-345. PubMed ID: 29463381
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo.
    Kishan Kumar YH, Rao GR, Gopal KV, Shanti G, Rao KV.
    Indian J Dermatol Venereol Leprol; 2009 May 17; 75(2):162-6. PubMed ID: 19293504
    [Abstract] [Full Text] [Related]

  • 38. The 308-nm excimer laser treatment does not increase the risk of skin cancer in patients with vitiligo: A population-based retrospective cohort study.
    Bae JM, Eun SH, Oh SH, Shin JH, Kang HY, Kim KH, Lee SC, Choi CW.
    Pigment Cell Melanoma Res; 2019 Sep 17; 32(5):714-718. PubMed ID: 30849210
    [Abstract] [Full Text] [Related]

  • 39. Dermatoscopic evaluation of treatment response in patients undergoing NBUVB phototherapy for the treatment of non-segmental vitiligo: A prospective study.
    Nayak D, Vinay K, Dev A, Bishnoi A, Kumaran MS, Parsad D.
    Photodermatol Photoimmunol Photomed; 2023 May 17; 39(3):279-281. PubMed ID: 35953438
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of tretinoin 0.05% cream to prevent hyperpigmentation during narrowband UV-B phototherapy in patients with facial vitiligo: a randomized clinical trial.
    Ju HJ, Kim SH, Lee JH, Kim GM, Bae JM.
    J Dermatolog Treat; 2022 May 17; 33(3):1738-1741. PubMed ID: 32869680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.